# Fludeoxyglucose F 18

NDC: 52670-551
Generic name: Fludeoxyglucose F-18
Labeler / Manufacturer: Mayo Clinic
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20130805

FDA application: ANDA203612

## Active ingredients

- FLUDEOXYGLUCOSE F-18: 240 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"52670-551"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=52670-551
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=153b650d-7b69-4880-a72a-a5f13059d248